The biological reality of why a patient’s metabolic health dictates the survival path of pancreatic cancer has remained a persistent shadow in modern oncology. While clinicians have noted for years that obesity and type 2 diabetes correlate with worse outcomes, the actual genetic machinery
In the intricate world of pediatric neurology, the sudden onset of life-threatening seizures in a previously healthy infant remains one of the most harrowing experiences for families and clinicians alike. Dravet syndrome, a severe form of epilepsy that typically surfaces during the first twelve
The traditional pharmaceutical development cycle often requires more than a decade and billions of dollars to bring a single life-saving treatment from the laboratory bench to the patient’s bedside. While classical supercomputers have made significant strides in screening chemical compounds, they
The biological revolution of the current decade has granted scientists the unprecedented ability to map the smallest genetic variations that drive complex diseases, yet the physical and digital pipelines connecting these discoveries to real patients remain dangerously frayed. While laboratories
The long-held medical consensus that Parkinson’s disease represents a single path of neurological decay is crumbling under the weight of new evidence showing that patients are actually suffering from entirely different biological failures. For decades, the medical community categorized this
The medical community has long relied on visible motor symptoms like tremors and physical rigidity to diagnose Parkinson’s disease, yet these outward signs represent only the tip of a much deeper and more diverse biological struggle. Recent breakthroughs from the VIB-KU Leuven Center for
